Key result
New trial protocol evaluates a structured pharmacist and GP care model to reduce unplanned hospital readmissions.
Why the study?
A model of GP and pharmacist collaboration in primary care may reduce medication-related problems and support patients after hospital discharge, but its effect on hospital readmissions is unknown.
Does a multifaceted pharmacist and GP collaboration model reduce unplanned, all-cause hospital readmissions in high-risk patients recently discharged from the hospital?
RCT (n=2,240)
stepped-wedge, cluster-randomised
Yes
Does a multifaceted pharmacist and GP collaboration model reduce unplanned, all-cause hospital readmissions in high-risk patients recently discharged from the hospital?
No takes yet. Share an insight, caveat, or question.
This study protocol describes a cluster-randomized trial to evaluate whether a structured pharmacist and GP collaboration model reduces hospital readmissions in high-risk patients, including those with heart failure.
Foot et al. (2017) conducted an RCT in High-risk patients after hospital discharge (n=2,240). Structured pharmacist and GP care model vs. Usual care was evaluated on Rate of unplanned, all-cause hospital readmissions over 12 months. This is a study protocol for a stepped-wedge, cluster-randomized trial evaluating a structured pharmacist and GP care model to reduce unplanned hospital readmissions; no results are available.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: